GC announced on Thursday that it stopped the discussion on the contract manufacturing organization (CMO) agreement on Janssen's Covid-19 vaccine.In August, some media outlets reported that GC discussed a CMO agreement with Janssen for the latter's Covid-19 vaccine. However, the company has since sai
Samsung Pharm said it would withdraw its hotel business, which it started in 2020. Instead, the company said it would sell the land, planned for hotel construction to secure financial liquidity.The company sold the land to GemVax Zio, a subsidiary of GemVax & KAEL.In a public filing on Thursday, Sam
Koreans with acromegaly will likely experience more difficulties as they lose one of the two available second-line treatments.According to industry sources, the supply of Signifor Lar, an acromegaly treatment, has recently stopped. The halt in supply comes after Novartis, the original developer of t
SAN ANTONIO, Texas -- By Kim Yun-mi/Korea Biomedical correspondent - Novartis said its CDK4.6 inhibitor Kisqali (ingredient: ribociclib) improved overall survival (OS) across subtypes of metastatic hormone receptor-positive breast cancer, according to results of phase 3 MONALEESA studies presented a
Celltrion said that Regkirona (ingredient name: Regdanvimab), its Covid-19 antibody, has obtained conditional approval from the Australian Therapeutic Goods Administration (TGA).The Australian health authorities have approved provisional registration of Lekkona for adults with mild and moderate symp
Eyegene said Tuesday that the government would support its recruitment of patients to help conduct the clinical trials of the Covid-19 mRNA vaccine.The announcement drew industry watchers’ attention to whether the state support would facilitate the development of a homegrown Covid-19 vaccine.Accordi
Bertis, a precision medicine development firm, said Tuesday that it would cooperate with the National Cancer Center Research Institute (NCCRI) to research and develop a proteomics-based cancer diagnosis and treatment.The company added that the two partners would actively collaborate to conduct clini
Hanmi Pharmaceutical said that Spectrum, its U.S. partner, submitted a new drug application (NDA) for poziotinib, a non-small cell lung cancer (NSCLC) treatment, to the U.S. Food and Drug Administration on Monday.Hanmi explained that Spectrum submitted the NDA based on positive cohort 2 results of t
Daewoong Pharmaceutical said it would begin a phase 1 trial of Enavogliflozin (DWP161001), a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for type-2 diabetes, targeting multiple ethnic groups.On Wednesday, the company received approval from the Ministry of Food and Drug Safety (MFDS) to conduct
A global medical affairs executive at Moderna said the company’s Covid-19 vaccine was safe and effective not only for adults but children.He emphasized the vaccine’s safety amid the rising demand for booster shots, sparked by a recent spread of the highly transmissible Omicron variant.On Thursday, R
Biopharmaceutical stocks, which drew attention as Covid-19’s beneficiaries last year, seem to have been mired in a slump, as shown by declining share prices and dwindling market capitalization since September, analysts said on Friday.Ironically, their slump mainly resulted from the rising inoculatio
The Ministry of Food and Drug Safety has revoked the license of Hugel and Pharma Research Bio's botulinum toxin (BTX) products for selling their products in the domestic market without winning the governmental shipment approval.The governmental shipment approval is a system that obligates the makers
Moderna Korea said that it has appointed Sohn Ji-young as its first general manager.Sohn will form a team to lead Moderna's business in Korea. The recruitment process for new employees is going on, and the company plans to establish its Korean office in Seoul.According to the company, Sohn is a phar
Medytox Korea, a subsidiary of Medytox, said on Tuesday that it has completed recruiting patients for a local phase 3 trial of a next-generation botulinum toxin (BTX) MBA-P01.Medytox Korea started developing MBA-P01 as a new type of BTX in 2016.Unlike existing BTX products that come in freeze-dried
Eutilex said that it has agreed with Microuni to jointly research a next-generation mRNA expression system to develop an infectious disease and anticancer vaccine. Microuni is a bio venture established by a research team at Chungbuk National University Medical School.The two companies plan to utiliz
Hugel said that the European Medicines Agency (EMA) has granted good manufacturing practice (GMP) certification to its Geodu Plant that manufactures the company's botulinum toxin (BTX) product, Letybo.Geodu Plant, located in Chuncheon, Gangwon Province, is Hugel's second BTX factory with a productio
Bayer Korea said Thursday that Verquvo, its chronic heart failure treatment, obtained product approval from the Ministry of Food and Drug Safety on Nov. 30.Hospitals can use the treatment along with other heart failure medications on chronic heart failure patients who recently received intravenous d
Hyundai Bioscience said on Wednesday that it would expand the indication of its oral antiviral agent CP-COV03 (ingredient: niclosamide).The biotech company is repurposing niclosamide, an anti-parasitic drug, as a Covid-19 treatment. The investigational drug’s indication will also include influenza t
Roche Korea said it would actively expand new drugs in Korea at an online press conference, marking the 125th anniversary of the foundation of Roche Group.With the conference title, “We are Roche – The Future of Healthcare,” the company presented Roche Grou’s achievements in the past 125 years, visi
Pfizer Korea said that the Ministry of Food and Drug Safety has approved Mylotarc as the first-line treatment of newly diagnosed CD33-positive adult patients with acute myeloid leukemia (AML).The ministry based its approval on an open-label, randomized, multicenter, phase 3 ALFA-0701 clinical trial